Triketones

Apr 29, 2020

Sumitovant Biopharma Announces Publication of Myovant Abstracts Detailing Additional Efficacy and Safety Findings from Phase 3 Liberty Studies in Uterine Fibroids in Obstetrics & Gynecology

Apr 24, 2020

Sumitovant Biopharma Reports Key Clinical and Regulatory Milestones by Myovant Sciences

Jun 19, 2019

World Endometriosis Markets, 2014-2019 & 2019-2026: Key Pipeline and Marketed Drugs, Clinical Trials, Upcoming and Regulatory Events, Patent Information, Licensing and Acquisition Deals

May 16, 2019

Data Analysis Published in Hypertension Shows Responders to Pegloticase Treatment Had Significant Decreases in Blood Pressure

May 14, 2019

Roivant Statement on Positive Phase 3 Results from Myovant's LIBERTY 1 Study in Uterine Fibroids

Jan 17, 2019

Acquist Announces Issuance of Two U.S. Patents Covering its Drug Library of Novel Small Molecules

Aug 22, 2018

Study Finds Salivary Uric Acid May Be an Important Biomarker for Indexing Health & Disease Risk

May 08, 2018

Ninhydrin Hydrate Market 2018-2023: Focus on Global and Chinese Industry - ResearchAndMarkets.com

Oct 11, 2017

Relburn-Metabolomics to Present Developments in Lead Programs for NASH and Gout

Aug 03, 2017

Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101